[1]BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
[2]AN J,SEOK H,HA EM.GABA-producing Lactobacillus plantarum inhibits metastatic properties and induces apoptosis of 5-FU-resistant colorectal cancer cells via GABA(B) receptor signaling[J].J Microbiol,2021,59(2):202-216.
[3]BOLEIJ A,HECHENBLEIKNER EM,GOODWIN AC,et al.The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients[J].Clin Infect Dis,2015,60(2):208-215.
[4]WANG JW,KUO CH,KUO FC,et al.Fecal microbiota transplantation:Review and update[J].J Formos Med Assoc,2019,118(Suppl 1):S23-S31.
[5]WEN X,WANG HG,ZHANG MN,et al.Fecal microbiota transplantation ameliorates experimental colitis via gut microbiota and T-cell modulation[J].World J Gastroenterol,2021,27(21):2834-2849.
[6]桂冠,易健,张善金,等.粪菌移植疗法治疗晚期结直肠癌FOLFIRI化疗方案相关难治性腹泻的效果观察[J].中国医学创新,2021,18(30):10-14.
GUI G,YI J,ZHANG SJ,et al.Effectiveness of fecal bacteria transplantation therapy in treating refractory diarrhea associated with FOLFIRI chemotherapy regimen in advanced colorectal cancer[J].China Medical Innovation,2021,18(30):10-14.
[7]孟敏,刘凯,杨雪,等.粪便菌群移植治疗难辨梭状芽孢杆菌感染有效性及安全性的系统评价再评价[J].中国循证医学杂志,2017,17(11):1318-1324.
MENG M,LIU K,YANG X,et al.Re-evaluation of systematic evaluation of the effectiveness and safety of fecal flora transplantation for Clostridium difficile infection[J].Chinese Journal of Evidence-Based Medicine,2017,17(11):1318-1324.
[8]ZAINAH H,HASSAN M,SHIEKH-SROUJIEH L,et al.Intestinal microbiota transplantation,a simple and effective treatment for severe and refractory clostridium difficile infection[J].Digestive Diseases and Sciences,2014,60(1):181-185.
[9]SOUGIANNIS AT,VANDERVEEN BN,ENOS RT,et al.Impact of 5 fluorouracil chemotherapy on gut inflammation,functional parameters,and gut microbiota[J].Brain Behav Immun,2019,80:44-55.
[10]CHEN ML,SUNDRUD MS.Xenobiotic and endobiotic handling by the mucosal immune system[J].Curr Opin Gastroenterol,2018,34(6):404-412.
[11]董拓周,公雪,李大林.菌群移植联合PD-L1抑制剂及化疗治疗三阴性乳腺癌的展望[J].现代肿瘤医学,2023,31(6):1177-1180.
DONG TZ,GONG X,LI DL.Prospect of fecal microbiota transplantation combined with PD-L1 inhibitors and chemotherapy in the treatment of triple-negative breast cancer[J].Modern Oncology,2023,31(6):1177-1180.
[12]OTA K,TAKEUCHI T,KOJIMA Y,et al.Fluoropyrimidine-induced intestinal mucosal injury is associated with the severity of chemotherapy-related diarrhea[J].Scand J Gastroenterol,2019,54(2):227-232.
[13]CHENG H,ZHAO L,JU Z,et al.Effects of 10.6-μm laser moxibustion and electroacupuncture at ST36 in a 5-FU-induced diarrhea rat model[J].Support Care Cancer,2021,29(5):2561-2569.
[14]董文钦,朱耀东,李平,等.亮菌口服液对5-FU化疗后小鼠肠黏膜屏障及肠道菌群移位的影响[J].安徽医科大学学报,2019,54(7):1066-1071.
DONG WQ,ZHU YD,LI P,et al.Effects of Leuconostoc oral solution on intestinal mucosal barrier and intestinal flora shift in mice after 5-FU chemotherapy[J].Journal of Anhui Medical University,2019,54(7):1066-1071.
[15]SI X,BI J,CHEN Q,et al.Effect of blueberry anthocyanin-rich extracts on peripheral and hippocampal antioxidant defensiveness:The analysis of the serum fatty acid species and gut microbiota profile[J].J Agric Food Chem,2021,69(12):3658-3666.
[16]HIRANO T.IL-6 in inflammation,autoimmunity and cancer[J].Int Immunol,2021,33(3):127-148.
[17]FOEGEDING NJ,BYNDLOSS MX.Taking on cancer[J].Cell Host Microbe,2021,29(6):851-853.
[18]袁静,缪洪明.肿瘤相关巨噬细胞MGLL缺失促进免疫抑制和结直肠癌细胞腹腔种植转移[J].陆军军医大学学报,2023,45(6):530-538.
YUAN J,MIU HM.MGLL deficiency in tumor-associated macrophages promotes immunosuppression and metastasis of colorectal cancer cells by abdominal implantation[J].Journal of Army Medical University,2023,45(6):530-538.
[19]CHEN D,WU J,JIN D,et al.Fecal microbiota transplantation in cancer management:Current status and perspectives[J].Int J Cancer,2019,145(8):2021-2031.
[20]金梁,李慧杰,王信,等.肠道菌群与结直肠癌发生及中医药调节作用的研究现状[J].现代肿瘤医学,2022,30(18):3412-3415.
JIN L,LI HJ,WANG X,et al.Research status of intestinal flora and colorectal cancer occurrence and regulation of traditional Chinese medicine[J].Modern Oncology,2022,30(18):3412-3415.
[21]HAN S,PAN Y,YANG X,et al.Intestinal microorganisms involved in colorectal cancer complicated with dyslipidosis[J].Cancer Biol Ther,2019,20(1):81-89.
[22]RIQUELME E,ZHANG Y,ZHANG L,et al.Tumor microbiome diversity and composition influence pancreatic cancer outcomes[J].Cell,2019,178(4):795-806.